Sign In

Society News

Breaking News

Amazon shoppers: use AmazonSmile to support ACS

Prime Days on June 21 and 22 are a big revenue opportunity for ACS!

Heads up, Amazon shoppers – Prime Days are just around the corner. This year, June 21 and 22 are the days for deals, and for potential revenue for ACS. 

On Prime Days (and every day!), when Amazon shoppers select ACS as their charity of choice via, the company will donate 0.5% of eligible purchases to ACS. This comes at no cost to shoppers! If you already shop at Amazon, we can’t think of a good reason not to enroll in AmazonSmile. 

There are three ways to shop via AmazonSmile:

  1. Start your shopping experience by clicking on ACS’s custom AmazonSmile link:   
  2. Go to and select the American Cancer Society as your charity of choice, then start each visit at
  3. Do your shopping via the AmazonSmile app. Follow these instructions

To date, ACS has received nearly $1.5 million in revenue from this program – real dollars to support our mission!

Action for social media

Share this opportunity with your social network. Our Masterbrand social media channels will be promoting this opportunity, so feel free to RT or share those posts when you see them. 

  • TOMORROW, 8 - 9:15 p.m. ET: Volunteer Day of Understanding

    Please register by Monday, June 14.

    We hope you can join us for the final session of the Volunteer Impact Series. This series highlights how volunteers can make an impact on the American Cancer Society's mission to save lives, celebrate lives, and lead the fight for a world without cancer.

    The Volunteer Day of Understanding on Tuesday, June 15, will be a moderated panel discussion with volunteer leaders to examine the organization's role in addressing systemic racism and creating and sustaining an organizational culture that centers on diversity, equity, and inclusion. This will be the first-time volunteers will be able to participate in a Day of Understanding.

    This session will run from 8-9:15 p.m. ET. We've also dedicated time during the virtual event for our panelists to answer your questions. Here is the agenda:

    • Opening Remarks
    • Video Presentation
    • Panel Discussion
      • Dr. Rick Ngo, surgeon, ACS CAN Board member, Houston, TX
      • Kira Sano, RFL event lead, student at University of Southern California, San Francisco, CA
      • Kier Matthews, development & account management leader, ACS Area Board member, Seattle, WA
      • Dr. Omar Rashid, oncologist, ACS Area Board member, Orlando, FL
      • Carlos Velasco, Latino community facilitator and consultant, Phoenix, AZ
    • Call to Action

    Volunteers must register to participate by Monday, June 14. If you registered prior to the first session on April 20 or the second session on May 11, you do not need to register again. A link to join the session will be emailed to you at the email address provided prior to the session.

    You are encouraged to invite other dedicated volunteers to join this important discussion.

    Replays of session 1 and session 2 are available.  

    If you have any questions, please contact Kathy Oaks, senior volunteer engagement manager.

  • ACS National Consortium hosts first Issue Hub

    ​300 attendees learn how to boost cancer screening rates.

    As part of our comprehensive effort to increase cancer screening rates, we launched a national consortium this spring to engage a diverse and influential group of leaders. 

    On June 1, the consortium welcomed over 300 attendees to participate on our inaugural Issue Hub titled “Accelerating What We Know Works in Cancer Screening and Care.” National Consortium Issue Hubs are facilitated panel discussions with renowned subject matter experts who are challenged to identify, deliberate, and build consensus around the most pressing issues in the recovery and improvement of cancer screening and care nationwide. 

    This was the first of three planned Issue Hubs this year.

    This session explored key areas of national alignment in the implementation of evidence-based and emerging cancer screening activities. Moreover, the information gathered during this Issue Hub is critical to the future conversations and decision-making of the National Consortium. 

    The panel for this Issue Hub reflected the level of thought-leaders and influential voices we hope to continue gathering around our virtual table. Panelists included:        

    • Keysha Brooks-Coley, MA – vice president, Federal Advocacy and Strategic Alliances, ACS CAN
    • Timothy Mullet, MD, FACS – chair, Commission on Cancer of the American College of Surgeons
    • Lisa Richardson, MD, MPH – director, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC
    • Robert Smith, PhD – senior vice president, Cancer Screening, ACS
    • John Williams, MD, FACS – chair, President’s Cancer Panel
    • Discussion Lead: Rich Wender, MD –  chair, Family Medicine and Community Health University of Pennsylvania; chair, National Colorectal Cancer Roundtable

    Throughout the 90-minute session, panelists shared their best thinking on:

    • The factors, big and small, that prevent us from seeing the outcomes we want to see in cancer screening and care.
    • How to accelerate adoption of proven cancer screening and care activities to reach our desired outcomes.
    • The innovations or opportunities necessitated by the pandemic that we could leverage to expand our capacity in cancer screening and care.

    Attendees were invited to engage via virtual meeting tools, including live polling and idea boards. 

    The National Consortium’s next Issue Hubs are tentatively scheduled for August and November. Panelists will rotate so that stakeholders around the country can listen to, learn from, and ideate with a variety of public health leaders, researchers, clinicians, and other thought leaders.  

    Early survey results indicate an appetite for participation on these events: 

    • 97% thought the overall session was excellent or good
    • 99% would like to attend another Issue Hub
    • 97% would like to stay connected with the National Consortium efforts
    • 94% would recommend attending an Issue Hub to a colleague 
    • 92% learned something new and 91% learned something they would consider valuable

    National Consortium members will reconvene on June 17 in a virtual summit to further consider the discussion of our first Issue Hub and look to provide actionable recommendations which are necessary to not just accelerate our recovery from the pandemic, but also accelerate our resilience and overall improvement in providing quality cancer screening and care for all. 

    A recording of the June Issue Hub is available here. A summary report of the Issue Hub will be made available by June 18. For questions about the consortium, contact Sarah Shafir or Caleb Level. View a list of the consortium members.

    About ACS’s National Consortium

    ACS and ACS CAN have organized mission priorities and program work to effectively respond to consequences from the COVID-19 pandemic on cancer screening and care. The National Consortium, which focuses on accelerating, strengthening, and mobilizing, is one component of this initiative. It is an issue-focused, time-bound partnership that is dedicated to the acceleration of a national response to the COVID-19 pandemic in relation to its detrimental impact on our collective progress in cancer screening and care across the U.S. Our overall return to screening effort is supported by Genentech, Pfizer, Merck, and the National Football League. 

  • 20 fun insights into our new CEO

    Our new CEO was kind enough to answer some personal questions to help us get to know her better. Below is a quick Q&A that pulls back the curtain into her personal life a bit.

    1. Where were you born and raised? I was born in Baltimore but lived there only 10 days. I was raised in a military family (my father was Special Forces—the first intelligence officer of Delta Force), so we moved frequently. I did my undergraduate work in Washington D.C. (at George Washington University), my doctorate in California (Univ. of California at San Diego), and my fellowship at the Ludwig Institute for Cancer Research in La Jolla, CA. My first faculty appointment was at the University of Cincinnati College of Medicine, until I was recruited to Philadelphia in 2007 by the Sidney Kimmel Cancer Center at Jefferson. I have lived in Philadelphia longer than anywhere in my life, and consider myself a true Philadelphian!

    2. What was your favorite college class? Genetics. Probably not a surprise, but I had a transformative professor.

    3. What are you looking forward to most once the pandemic is behind us? I’m looking forward to family holidays that include all three generations. It’s been so difficult to quarantine away from our parents.  

    4. What’s your favorite vacation spot? This is easy—Malta. I am fortunate to have a large family there and we visit the aunties, uncles, and cousins every other year. For me, Malta is my happy place. It is unquestionably beautiful, magically historic, and with a culture that is oriented to compassion, family, and charity.

    5. Did you do anything interesting during the pandemic – take up a hobby for example? While I didn’t take up any new hobbies, it was for a good reason. The entire cancer care and cancer research program was appropriately considered “essential”— as such, we were on site and working harder than ever. I remain so proud of the entire Sidney Kimmel Cancer Center (SKCC) team that I had the privilege to lead. I will always remember the heroism of the staff, faculty, students, and providers who ensured that our mission to defeat cancer marched onward without pause. Most critically, our ability to work together as a highly functional, nimble, and mission-oriented team allowed us to react rapidly to the onset of challenges and to ensure the safe continuation of serving our cancer patients. I could not be more thankful for the SKCC team!

    6. What is the most important quality of a good leader? I have been positively impacted by so many exceptional leaders during the course of my career, and have continued to refine my own style in leading a cancer research laboratory, a major academic department, a multi-state cancer program, and as president of the Association of American Cancer Institutes. While there are many qualities that I appreciate in leaders, e.g. integrity, transparency, empathy, agility, courage, creativity, self-awareness, perhaps one of the most important from my view is to lead with purpose. It is without question that the American Cancer Society exists because the burden of cancer is unacceptably high, and we believe that we can improve the lives of cancer patients and their families through advocacy, discovery, and patient support. As CEO, it is my hope that all of YOU will hold me accountable to orienting decisions and structures toward this purpose. We are one ACS, with one mission against cancer.  All of us are “mission.”

    7. When you think of your favorite boss, what quality did you appreciate most? My CEO at Jefferson, Dr. Stephen Klasko, has been a tremendous leader. Jefferson’s significant rise was a direct result of Dr. Klasko’s inspiring vision and ability to lead a 33,000 employee organization to “be bold, think differently, and do the right thing.” His vision was clear, and under his leadership, courage and innovation were highly valued. It is my goal to ensure that at ACS we similarly undertake a “no limits” approach to using advocacy, research, and patient support to improve the lives of cancer patients.

    8. Describe the perfect day off from work. A perfect day off work would start with sleeping in until at least 7 a.m., chatting with my husband over a latte, spending the day all together as a family doing something we all enjoy (hiking, skiing, traveling), and capping off the evening by sharing the kitchen with our sons to make a family dinner. We all love to cook, so gathering around the table with something we all prepped together is a true joy!

    9. Do you follow sports? If so, what are your favorite teams? Did I mention how much I love Philadelphia? I am an avid Phillies, Eagles, and 76ers fan, and as of late have also been following the Flyers. We have an incredible sports town, and no, no one has actually thrown a snowball at Santa since the 1960’s. I’m part of the effort to try and improve the Philly sports fan image. 

    10. What’s your favorite board game to play? I love this question, yet it is impossible to answer. To say that our family is addicted to board games would be an understatement; it’s an almost nightly event. While there are no true favorites, when we are together with the grandparents we turn to QuiddlerYahtzee, or Tripoley. Our sons gravitate toward strategy games you might not have heard of but that we all really enjoy—7 WondersEthnosSplendor. We had to stop playing Pictionary because our son Dylan and his girlfriend Carley are unstoppably amazing and no one can beat them; it was frustrating. On holiday, we roll out games that can be packed into small suitcases – one of our favorites is a game from when the kids were small — Wild Vikings. When just the two of us, Brian and I enjoy facing off over Scrabble. In short, in our world there is no day when a board game is a bad idea.

    11. What’s one thing we’d always find in your refrigerator? Milk, because you never know when an emergency latte or cappuccino is needed. Also, I just like milk!

    12. What’s on your bucket list? I’d like to go back to the Arctic Circle during winter and to see the Northern Lights.

    13. What phone app do you use most? Since the sad but true answer are my email and calendar apps, I will say that the third most used is the iBooks app. I do enjoy reading quite a bit, so having a good book handy at all times is an “iPhone must-do.”

    14. How do you keep up with the news? So many ways! I still enjoy the newspaper (although I read it electronically), but I listen to NPR during my morning drive, and of course often learn of news first through social media. I hope you will connect with me on Twitter! (Find her on Twitter: @AmerCancerCEO)

    15. What’s your favorite type of music? I enjoy all types of music —  classical, opera, classic rock, modern rock, blues, world music, etc. We dance around the kitchen quite a lot. True to form, on Saturdays at 5 p.m. ET you will generally find us tuned in to “The Many Moods of Ben Vaughn” on our local college radio station. I would love to be his guest co-host, broadcasting from the relay shack in “Parts Unknown, USA.”

    16. What’s the best career advice you ever heard? Do what you love, lead with purpose, and be the leader who sees opportunities to think differently rather than obstacles.

    17. Have you achieved a good work-life balance? I think so. While it’s true that I am always “on” and available, I do find ways every day to connect meaningfully with my family, enjoy life, and laugh. I am very fortunate to be part of a loving family.

    18. What’s your favorite food? Artichokes. What’s not to love?

    19. What’s your favorite type of exercise? While I reluctantly use the treadmill and generally enjoy the Peloton, I much prefer exercise as part of sports or outdoor adventures. Favorites include hiking, skiing, golf, and swimming. I also like to take batting practice or just have a catch in the yard, but it’s hard to find the time these days. 

    20. Do you have a favorite movie? Another trait we all share in the family is a love of movies. From arthouse to superhero, we indulge and delight in all genres! Philadelphia is a terrific movie town with our own film festival. One thing is for certain—in successfully raising two boys I can say that my knowledge base of Lord of the RingsHarry Potter, and Star Wars is exceptionally high. If I had to choose a favorite set of movies, I would probably go with Cold Comfort Farm for the comedy category (also a great book, btw—Stella Gibbons was a genius of comedy); La Vita e Bella in the foreign film category; Spirited Away in the animated category; Inception in the suspense category; and The English Patient or The Godfather in the overall category. I bet you thought I was going to say Rocky, didn’t you?

  • NCI showcases ACS Senior Scientific Director Rebecca Siegel’s CRC research

    This year marks the 50th anniversary of the National Cancer Act of 1971, which created a national commitment to making progress against cancer. The law established the National Cancer Institute (NCI) in its current form and represented the US’s commitment to the “war on cancer,” as then-President Nixon described it.

    To highlight progress against cancer since the law’s inception, the National Cancer Institute this year is sharing groundbreaking developments in cancer research. One of the brilliant scientists featured on their website right now is our own Rebecca Siegel, MPH, senior scientific director, Surveillance Research.

    The article shares how Becky examined data from the NCI’s SEER program and other cancer databases to uncover an increase in the number of people under 50 being diagnosed with colorectal cancer, which led ACS to lower our CRC screening age from 50 to 45 in 2018, no doubt saving countless lives. The USPSTF just followed suit last month, joining ACS in recommending people at average risk begin screening for CRC at age 45.

    Congrats to Becky on this well-deserved recognition! This is a terrific example of the kind of research and innovation ACS is known for. Be sure to check out the story – it’s a great read!

  • Monthly Advocacy Update - June 2021

    ​A message from Lisa Lacasse, ACS CAN president. 

    A tremendous amount of work occurred in May as ACS CAN volunteers and staff continue to advocate, across the country, day and in and day out, on behalf of cancer patients, survivors and those at risk of the disease. As policy discussions ramp up on Capitol Hill and  legislative sessions continue in many state, the last month brought meaningful progress in a variety of our priority issues, including increasing funding for state tobacco control and cancer prevention programs and ensuring patient affordability of cancer prevention and care. We also led fellow cancer advocates during the One Voice Against Cancer (OVAC) coalition’s annual Lobby Day to urge lawmakers to increase research funding for the National Institutes of Health and National Cancer Institute, investment that we know is critical to advancing our fight against cancer.  

    June is shaping up to be a very exciting month! The ACS CAN senior leadership team is thrilled to spend time with Dr. Karen Knudsen this week in D.C. as she launches her tenure as the first female CEO of the American Cancer Society and ACS CAN. It will be our first in-person work meeting since the early months of 2020. ACS CAN is also closely monitoring for the anticipated Supreme Court ruling in California v. Texas, the case challenging the constitutionality of the Affordable Care Act, and will issue a statement as soon as the ruling is announced.

    President Biden’s Budget Focuses on Health Issues, Boosts Biomedical Research
    Late last week the Biden administration released its budget for fiscal year 2022, which focuses on health issues like biomedical research and access to care. Overall, ACS CAN welcomes and is excited by the clear commitment to ‘end cancer as we know it,’ including: 

    • An additional $9 billion in funding for the National Institutes of Health (NIH), including $6.5 billion to create a new agency called the Advanced Research Project Agency on Health (ARPA-H) dedicated to accelerating biomedical research for rare and difficult to treat diseases like cancer. 
    • Increased funding for the Centers for Disease Control and Prevention’s (CDC) Social Determinants of Health program.
    • Making marketplace health plans more affordable through increased subsidies and lower deductibles is a positive step forward in increasing access to care for patients and survivors. 
    • First-time funding to create a national comprehensive paid family and medical leave program that includes leave for serious illness and caregiving. 

    We urge lawmakers to also prioritize funding for the National Cancer Institute and the CDC’s cancer prevention and early detection program or the Office on Smoking and Health, which are essential to our work to significantly reduce the cancer burden. Read more in our press statement. 

    ACS CAN Survey Shows Cancer Patients and Survivors Continue to Face Pandemic-Related Health Care Delays

    ACS CAN’s latest Survivor Views survey makes clear that there is more work to be done to ensure patients and survivors can get the health care they need. One in three (35%) of cancer patients and survivors report that the COVID-19 pandemic has affected their ability to access care, with 1 in 6 (16%) reporting a delay or interruption in their cancer screening schedule during the last few months. These delays were driven mostly by staffing shortages or lack of available appointments and patients’ concerns about contracting coronavirus.

    Our survey also asked patients about overall cancer care experience, and responses showed continued racial, ethnic and socioeconomic disparities in the health care system. Fifteen percent of Hispanic, American Indian or Asian patients did not feel like an active participant in their treatment decisions compared to 12% of white respondents. Additionally, 36% of respondents ranked the cost of health care as the most important challenge facing cancer patients and survivors. Read more in our press statement. 

    Updated Colorectal Cancer Guidelines Lower Screening Age to 45, Aligning with ACS guidelines and Expanding Insurance Coverage of Screenings

    The United States Preventive Services Task Force (USPSTF) released updated guidelines for colorectal cancer screenings, lowering the age for recommended screening from age 50 to age 45 for average risk individuals and aligning with the most recent American Cancer Society guidelines released in 2018. This final recommendation means that colorectal cancer screenings for individuals starting at age 45 are required to be covered with no copay by ACA-compliant plans.  ACS CAN will work to notify policymakers, insurance commissioners and state Medicaid directors about this change. These changes reflect the rising incidence of colorectal cancer in younger adults. To date, ACS CAN has helped to pass laws mandating coverage for colorectal cancer screenings beginning at age 45 in 9 states, and will continue to advocate at the state level because we know cost is a major barrier for patients getting screened and removing these barriers will help move our mission forward as we work to end suffering and death from cancer. Read our joint press statement with ACS here.

    #CancerVoice: Advocates Urge Congress to Prioritize Research Funding 

    Nineteen ACS CAN volunteers joined other cancer advocates for the One Voice Against Cancer (OVAC) coalition's annual lobby day. ACS CAN is the founder and leader of OVAC, a group of leading nonprofits unified by the importance of cancer research and prevention funding. This year’s OVAC Lobby Day was the largest ever with 138 participants meeting virtually with lawmakers to ask them to increase funding for the National Institutes of Health and National Cancer Institute as well as for the Centers for Disease Control and Prevention’s cancer control programs. Advocates also participated in an online Day of Action with the hashtag #CancerVoice

    Earlier in the month, OVAC members sent a letter to Congress urging for the inclusion of $10 billion in emergency funding in the forthcoming American Jobs Plan, to restart cancer research and clinical trials at the NIH stalled by the COVID-19 pandemic. Read the full letter here.

    Administration Takes Action to Preserve Anti-Discrimination Protections for LGBTQ Patients 

    ACS CAN and other patient groups praised the Biden administration’s action to preserve protections in the Affordable Care Act for lesbian, gay, bisexual, transgender and queer (LGBTQ) patients receiving health care services. The groups had previously filed an amicus brief in a lawsuit opposing the 2020 Rule that rescinded such protections for LGBTQ patients and individuals with limited English proficiency, making clear that discrimination of any kind would exacerbate existing health disparities and lead to poorer health outcomes. ACS CAN is strongly committed to protecting and expanding access to care for all cancer patients and survivors. Read the groups’ press statement here.

    ACS CAN Supports Legislation to Increase Federal Tobacco Tax

    ACS CAN sent a letter to members of Congress in support of recently introduced legislation that would double the federal cigarette tax rate, establish a federal tax on e-cigarettes and provide parity across all tobacco products. Significant tobacco tax increases are highly effective at reducing tobacco use, and produce a reliable and significant source of revenue for health care priorities that are so important to our cancer mission.

    State & Local Advances

    • ACS CAN applauded the Colorado General Assembly's approval of a budget bill that increases funding for mission-critical programs, including $4.5 million in new revenue for the state tobacco education, prevention and cessation programs; a $2.3 million increase for the state Cancer, Cardiovascular, and Pulmonary Disease prevention and education grant programs; and a $200K increase for the state breast and cervical cancer screening program. These funding increases stem from new revenues resulting from the tobacco tax ballot measure passed in 2020.
    • Florida Gov. DeSantis signed into law a bill that raised the legal age of sale for tobacco products to 21 but created a preemption law that blocks the power of elected officials at the local level to further protect the next generation from being addicted to deadly tobacco products. ACS CAN was outspoken about our strong opposition to the bill and advocated continuously against it. Media coverage of our reaction to the law being signed included The Hill, the Tampa Bay Times and Spectrum News 9. Allowing local governments to introduce and pass public health policies that best fit their communities is critical to advancing best practices across the country. Passing public health policies at the local level creates an opportunity for community debate, education and engagement that is unparalleled at the state or federal level. Florida advocates will continue to fight at all levels of government for meaningful action that protects youth from the tobacco industry and its dangerous products. 
    • The Illinois Legislature passed legislation that ACS CAN strongly advocated for which will require health insurers to offer more plans with flat-dollar copayments for prescription drugs. This important legislation will make prescription drug out-of-pocket costs more predictable for patients facing serious illness, enabling patients to budget and financially plan for their required medications. Another piece of legislation that passed will expand coverage of biomarker testing, which is an essential step to increasing patient access to precision medicine treatments.  
    • ACS CAN and its partners successfully advocated for Kansas Gov. Kelly to veto a bill that would have exposed more individuals to inadequate, short-term limited-duration health plans that are not required to provide the patient protections required by federal law. ACS CAN applauded the move and encouraged state lawmakers to direct efforts to expanding access to affordable, comprehensive health care coverage through Medicaid for Kansans.   
    • ACS CAN expressed strong objection when Missouri Gov. Parson failed to uphold the will of voters – who approved Medicaid expansion via ballot measure last August – and withdrew the request to expand coverage as of July 1 after the legislature failed to include specific funding for expansion, denying an estimated 271K Missourians access to health insurance through the Medicaid program. Significant media coverage of our opposition was garnered including NPR and the Associated Press
    • The Texas legislature voted unanimously to pass a bill ensuring insurance coverage of colorectal screenings starting at age 45, and removing cost sharing for a follow-up colonoscopy following a positive stool-based screening test. ACS CAN volunteers and staff advocated throughout the legislative session in support of removing a major financial barrier that kept too many Texans from receiving their recommended screenings. ACS CAN also successfully advocated for legislation that passed in Illinois to remove cost sharing for a follow-up colonoscopy. Similar legislation passed in Arkansas and Rhode Island earlier this year. 

    Advocacy in the News 

  • Pandemic continues to negatively impact access to care

    A new survey shows that 35% of cancer patients and survivors reported their access to healthcare has been negatively impacted by the Covid-19 pandemic. The Survivor Views survey from the American Cancer Society Cancer Action Network (ACS CAN) also finds that even during the last few months, as the overall spread of the virus has begun to decline due to vaccinations, roughly 1 in 6 (16%) patients report a delay or interruption in their cancer screening schedule, including 1 in 10 (11%) who experienced a screening delay for a cancer with which they’d previously been diagnosed. These delays were driven mostly by logistical issues such as staffing shortages or a lack of available appointments (26%), followed by patients’ concerns about the risks of contracting the virus (22%).

    The survey also asked patients about their overall cancer care experience. Responses showed continued racial, ethnic, and socioeconomic disparities in the health care system. Seventy-eight percent of respondents said their health care provider asked them what they wanted from their treatment and made them an active part of their cancer treatment decisions. But 22%, or 1 in 5 said they were not asked or unsure and 15% of Hispanics, American Indian, or Asian patients said they did not feel they were actively involved in their own treatment decisions, compared to 12% of white respondents. In addition, survey respondents identified the overall costs of health care as the most important challenge to address and the top priority for improving health care. This issue is critical because it impacts the ability of cancer patients and survivors to afford all of their necessary treatments and services. ACS CAN is urging lawmakers to ensure cancer patients can get timely, affordable health coverage that allows them to access the care they need.

    To learn more about Survivor Views, visit

  • Where in the ACS world is Dr. Knudsen?

    Dr. Knudsen's first official day as CEO began at 7:30 this morning with a meeting with IT at our Hope Lodge in Atlanta. After that, in a deliberate attempt to focus on mission first, she was scheduled to meet with Chief Medical and Scientific Officer Bill Cance, MD, and his direct reports. The four-hour meeting, with a working lunch built in, was to be followed by a virtual call with the Governance Committee of the ACS Board of Directors. In between all that, she was expected to make her first call to an external partner: Ned Sharpless, MD, director of the National Cancer Institute. 

    Her fast-paced fact finding mission continues on Wednesday, when she meets with Southeast Region EVP Brant Woodward for a tour of our Hope Lodge in Atlanta, followed by a call with Board Chair John Alfonso, and then her first meeting with her newly expanded executive team: COO Kris Kim, CFO Kael ReicinMike Neal, senior EVP, Field Operations; Tim Phillips, chief legal and risk officer; Bill CanceMichael Reich, senior VP, Communications & Marketing; and Lisa Lacasse, president of ACS CAN. The day ends with a flight to Washington D.C.

    On Thursday, her third day on the job, she heads to our ACS CAN office in the nation's capital. There she meets with the ACS CAN senior leadership. It includes a call with ACS CAN leadership volunteers, another working lunch with a casual roundtable discussion, and then a virtual call with select ACS CAN staffers from across the country. Following that are separate one-on-one discussions with Howard Byck, senior VP, Corporate & Sports Alliances, and Tawana Thomas Johnson, VP, Diversity Equity & Inclusion, both of whom live in the area. The day will likely conclude with dinner at Centrolina, an Italian restaurant in northwest D.C., with Lisa Lacasse. How much do you want to bet she orders the 'artichoke four ways'? Read 20 fun insights into our new CEO to learn why. 

    After calls Friday morning, Dr. Knudsen will fly back home to Philadelphia. She plans to take up residence in ACS's office off Market Street in downtown Philly. On that same day, Dr. Knudsen plans to participate virtually in the ASCO Annual Meeting.

    Our new CEO's schedule will continue to be busy. She's been posting on Twitter for years with the handle @SKCCDirector. She'll now be posting from @AmerCancerCEO, so make sure to follow her. 

  • New health equity resources are available

    Data briefs provide the facts on racial and economic disparities impacting cancer.

    Health equity is widely recognized as one of the most important issues of our time, and it is a major priority for the American Cancer Society. We believe ALL people should have a fair and just opportunity to prevent, find, treat, and survive cancer – regardless of income, race and ethnicity, sexual orientation, gender identity, disability status, or where they live. 

    Our Health Equity team is often asked for data and talking points around cancer disparities as well as messaging and storytelling around the work ACS and ACS CAN are doing to advance health equity. 

    To help staff and volunteers better understand the racial and economic disparities that impact how people prevent, find, treat, and survive cancer – and feel more comfortable talking about those disparities – we’ve created a series of data briefs called The Facts on Our FightThe briefs offer facts on disparities and highlight health equity success stories across the country. 

    They’re available on Brand Toolkit now. Topics include:  

    These resources will be updated each year with the release of our Cancer Facts & Figures resource, as well as on an as needed basis.  

    And stay tuned: later this summer we’ll release a second set of briefs about LGBTQ+ communities, colorectal cancer disparities, the effects of COVID-19 on cancer disparities, and an overview of the Social Determinants of Health 

back to top